Basel Medical BMGL
NASDAQ BMGL
$4.68 -0.26 (-5.26%)
At close: Sep 3, 2026 · 4:00 PM EDT

Basel Medical (BMGL) Net Cash Flow (2023 - 2024)

Basel Medical (BMGL) posted Net Cash Flow of -$3.5 million for Q4 2024.

Analysis

Basel Medical (BMGL) Net Cash Flow (2023 - 2024) Analysis & Trends

Basel Medical has reported Net Cash Flow for 1 years, with the latest figure at -$3.5 million in Q4 2024.

  • Quarterly Net Cash Flow changed N/A year-over-year to -$3.5 million in Q4 2024, while the trailing twelve-month figure through Dec 2025 was -$3.5 million (changed N/A YoY) and the FY2025 annual result came in at $1.2 million, up 20.15% from the prior year.
  • Net Cash Flow steadied at -$3.5 million in Q4 2024 per BMGL's latest filing.
  • Over five years, Net Cash Flow peaked at -$3.5 million in Q4 2024 and troughed at -$3.5 million in Q4 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Cash Flow (Qtr)
1 HCA Healthcare 89.64 Bn 88.63 Bn 15.19 Bn 74.00 Mn
2 Tenet Healthcare 22.12 Bn 19.95 Bn 4.45 Bn -797.00 Mn
3 Encompass Health 12.07 Bn 11.93 Bn 1.34 Bn -29.90 Mn
4 Davita 11.85 Bn 11.16 Bn 1.16 Bn 25.63 Mn
5 Universal Health Services 10.14 Bn 10.00 Bn 3.29 Bn 19.58 Mn
6 Ensign 9.93 Bn 9.61 Bn 306.24 Mn -277.20 Mn
7 Chemed 6.89 Bn 6.85 Bn 221.47 Mn 23.37 Mn
8 Pacs 6.75 Bn 6.58 Bn 338.46 Mn -96.80 Mn
9 Concentra Group Holdings Parent 4.31 Bn 4.15 Bn 192.10 Mn 96.34 Mn
10 Basel Medical 7.33 Mn 6.54 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 -3.49 Mn
Dec 31, 2023 -417,700.00